Grufity logo
Grufity logo

Latest Velan Capital Investment Management LP Stock Portfolio

$159Million– No. of Holdings #49

Velan Capital Investment Management LP Performance:
2026 Q1: 2.41%YTD: 2.41%2025: 23.93%
Performance for 2026 Q1 is 2.41%, and YTD is 2.41%, and 2025 is 23.93%.

About Velan Capital Investment Management LP and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Velan Capital Investment Management LP reported an equity portfolio of $159.6 Millions as of 31 Mar, 2026.

The top stock holdings of Velan Capital Investment Management LP are PRAX, TARA, STRO. The fund has invested 20.3% of it's portfolio in PRAXIS PRECISION MEDICINES I and 9.2% of portfolio in PROTARA THERAPEUTICS INC.

The fund managers got completely rid off CIDARA THERAPEUTICS INC (CDTX), LANTHEUS HLDGS INC (LNTH) and RAPT THERAPEUTICS INC (RAPT) stocks. They significantly reduced their stock positions in MINERALYS THERAPEUTICS INC, SYNDAX PHARMACEUTICALS INC (SNDX) and KAZIA THERAPEUTICS LTD (KZIA). Velan Capital Investment Management LP opened new stock positions in ANTERIS TECHNOLOGIES GLOBAL, XENCOR INC (XNCR) and LYELL IMMUNOPHARMA INC (LYEL). The fund showed a lot of confidence in some stocks as they added substantially to IMMIX BIOPHARMA INC (IMMX), TENAX THERAPEUTICS INC (TENX) and CYTOMX THERAPEUTICS INC. (CTMX).
Velan Capital Investment Management LP Equity Portfolio Value
Last Reported on: 15 May, 2026

Velan Capital Investment Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Velan Capital Investment Management LP made a return of 2.41% in the last quarter. In trailing 12 months, it's portfolio return was 68.35%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
anteris technologies global3,885,000
xencor inc3,015,000
lyell immunopharma inc2,046,120
rocket pharmaceuticals inc1,054,820
nasus pharma ltd797,846
quoin pharmaceuticals ltd560,003
artiva biotherapeutics inc161,000
neumora therapeutics inc.156,000
New stocks bought by Velan Capital Investment Management LP

Additions

Ticker% Inc.
immix biopharma inc2,014
tenax therapeutics inc600
cytomx therapeutics inc.575
pmv pharmaceuticals inc108
corbus pharmaceuticals hldgs100
precision biosciences inc100
sutro biopharma inc64.15
esperion therapeutics inc ne42.15
Additions to existing portfolio by Velan Capital Investment Management LP

Reductions

Ticker% Reduced
mineralys therapeutics inc-92.72
syndax pharmaceuticals inc-92.31
kazia therapeutics ltd-54.9
avalo therapeutics inc-29.78
evommune inc-11.94
maplight therapeutics inc-5.63
inspiremd inc-2.05
Velan Capital Investment Management LP reduced stake in above stock

Sold off

Ticker$ Sold
trevi therapeutics inc-2,566,600
xilio therapeutics inc-108,834
cidara therapeutics inc-23,945,400
rapt therapeutics inc-3,657,960
lantheus hldgs inc-4,970,420
terns pharmaceuticals inc-2,828,000
pyxis oncology inc-46,000
ventyx biosciences inc-361,200
Velan Capital Investment Management LP got rid off the above stocks

Sector Distribution

Velan Capital Investment Management LP has about 75.1% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare75.1
Others24.9

Market Cap. Distribution

Velan Capital Investment Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MICRO-CAP
  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • NANO-CAP
Category%
MICRO-CAP38.4
UNALLOCATED24.9
MID-CAP22.1
SMALL-CAP10.4
NANO-CAP4.3

Stocks belong to which Index?

About 20.4% of the stocks held by Velan Capital Investment Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others79.6
RUSSELL 200020.4
Top 5 Winners (%)%
EDSA
edesa biotech inc
200.2 %
CNTX
context therapeutics inc
78.2 %
STRO
sutro biopharma inc
75.7 %
OVID
ovid therapeutics inc
36.2 %
evommune inc
32.2 %
Top 5 Winners ($)$
STRO
sutro biopharma inc
5.5 M
EDSA
edesa biotech inc
2.9 M
evommune inc
2.8 M
PRAX
praxis precision medicines i
2.8 M
IMMX
immix biopharma inc
1.5 M
Top 5 Losers (%)%
GOSS
gossamer bio inc
-89.4 %
JSPR
jasper therapeutics inc
-52.1 %
HRTX
heron therapeutics inc
-38.5 %
VRDN
viridian therapeutics inc
-36.5 %
VRCA
verrica pharmaceuticals inc
-36.3 %
Top 5 Losers ($)$
HRTX
heron therapeutics inc
-4.4 M
JSPR
jasper therapeutics inc
-2.5 M
abivax sa
-1.7 M
VRCA
verrica pharmaceuticals inc
-1.4 M
ESPR
esperion therapeutics inc ne
-1.4 M

Velan Capital Investment Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Velan Capital Investment Management LP

Velan Capital Investment Management LP has 49 stocks in it's portfolio. About 73.1% of the portfolio is in top 10 stocks. HRTX proved to be the most loss making stock for the portfolio. STRO was the most profitable stock for Velan Capital Investment Management LP last quarter.

Last Reported on: 15 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions